These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6143657)

  • 1. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
    Fallat ME; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nucleotide pyrophosphatase in Mullerian duct regression.
    Fallat ME; Hutson JM; Budzik GP; Donahoe PK
    Dev Biol; 1983 Dec; 100(2):358-64. PubMed ID: 6140197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid enhancement of Mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1982 Oct; 17(5):453-8. PubMed ID: 6897422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
    Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
    Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
    Weniger JP; Zeis A
    Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
    Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
    Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
    MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
    Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine-mediated apoptosis in reproductive tract development.
    Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
    Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
    Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
    Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
    Wang JJ; Teng CS
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian inhibiting substance binding and uptake.
    Catlin EA; Ezzell RM; Donahoe PK; Manganaro TF; Ebb RG; MacLaughlin DT
    Dev Dyn; 1992 Apr; 193(4):295-9. PubMed ID: 1511169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
    Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
    Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Mullerian-inhibiting substance a circulating hormone in the chick-quail chimera?
    Hutson JM; Donahoe PK
    Endocrinology; 1983 Oct; 113(4):1470-5. PubMed ID: 6688583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
    Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
    Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
    Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
    Weniger JP; Cate RL; Zeis A
    J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
    Hutson J; Ikawa H; Donahoe PK
    J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.